Cargando…
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
INTRODUCTION: An outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was reported in Wuhan, China, in mid-December 2019, and declared a pandemic by the WHO on 11 March 2020. Due to the unknown nature of the disease and the lack of specific drugs, several potential treatments wer...
Autores principales: | Arab-Zozani, Morteza, Hassanipour, Soheil, Ghoddoosi-Nejad, Djavad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397976/ https://www.ncbi.nlm.nih.gov/pubmed/32737100 http://dx.doi.org/10.1136/bmjopen-2020-039730 |
Ejemplares similares
-
COVID-19 in Iran: the Good, the Bad, and the Ugly Strategies for Preparedness – A Report From the Field
por: Arab-Zozani, Morteza, et al.
Publicado: (2020) -
Knowledge, Attitudes, and Practices Among the General Population During COVID-19 Outbreak in Iran: A National Cross-Sectional Online Survey
por: Kakemam, Edris, et al.
Publicado: (2020) -
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
por: Hassanipour, Soheil, et al.
Publicado: (2021) -
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
por: Hassanipour, Soheil, et al.
Publicado: (2022) -
Following PRISMA in a Systematic Review: Obligation or Authority?
por: Arab-Zozani, Morteza, et al.
Publicado: (2020)